BordaI. T.SloneD.JickH.: Assessment of adverse reactions within a drug surveillance program, J. Am. Med. Assoc.205: 645–647, 1968.
2.
CoullD. C.MarronA. C.CrooksJ.WeirR. D.: Drug monitoring in the health services, Hlth Bull. Scot. Home Hlth Dept.26: 38, 1968.
3.
CrooksJ.CalderG.WeirR. D.: Drugs in hospital, J. Roy. Coll. Physicians Lond.1: 233, 1967.
4.
EvansD. A. P.WhiteT. A.: Human acetylation polymorphism, J. Lab. Clin. Med.63: 394, 1964.
5.
FinneyD. J.: The design and logic of a monitor of drug use, J. Chron. Diseases18: 77, 1965.
6.
GilletteR.: Individually different responses to drugs according to age, sex and functional or pathological state. In: WolstenholmeG.PorterR., ed., Drug responses in man, London, Churchill (Ciba Foundation Volume), 1967.
7.
HurwitzN. A.WadeO. L.: The incidence of adverse reactions in relation to the use of drugs in hospital, Brit. Med. J.1: 531, 1969.
8.
JickH.SloneD.BordaI. T.ShapiroS.: Efficacy and toxicity of heparin in relation to age and sex, New Engl. J. Med.279: 284, 1968.
9.
Koch-WeserJ.SidelV. W.SweetR. H.KanarekP.EatonA. E.: Factors determining physician reporting of adverse drug reactions, New Engl. J. Med.280: 20, 1969.
10.
KuninC. M.FinlandM.: Persistence of antibiotics in blood of patients with acute renal failure. 3. Penicillin, streptomycin, erythromycin and kanamycin, J. Clin. Invest.38: 1509, 1959.
11.
LasagnaL.: The diseases drugs cause, Prospect. Biol. Med.7: 457, 1964.
12.
SeibertS.BrungesS.SoutterJ. C.MarondeR. F.: Utilization of computer equipment and techniques in prescription processing, Drug Intelligence, 1: 343, 1967.
13.
SeidlL. G.ThorntonG. F.: Smith, J. W. and Cluff, L. E.: Studies on the epidemiology of adverse drug reactions. 3. Reactions in patients on a general medical service, Bull-Johns Hopkins Hosp.119: 299, 1966.
14.
SidelV. W.Koch-WeserJ.BarnettO.EatonA.: Drug utilisation and adverse reactions in a general hospital, Hospitals41: 80, 1967.